Cost-Effectiveness Of Dabigatran Versus Factor Xa Inhibitors For Stroke Prevention In Patients With Non-Valvular Atrial Fibrillation Under The Private And Public Health Care System In Brazil
Abstract
Authors
N.B. Santoni T.G. Melo E.P. Almeida